Camber Spine Continues to Add to its “All Angles” Product Portfolio with Latest Patent Approval

Camber Spine, a leading innovator in spine and medical technologies has announced that it has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for its Variant Retractor technology, bringing the company’s total patent portfolio to 47 patents.

The Variant Retractor is a tool designed to provide flexible spacing support for a variety of spine surgical approaches.

“As our IP portfolio continues to grow, so too does the positive impact we can make for our surgeon customers and their patients,” said Camber Spine Co-Founder and CEO, Daniel Pontecorvo.  “With this latest patent grant from the USPTO, we have now received 47 issued patents, further strengthening our value proposition of offering a broad selection of tools to surgeons that accommodate spine surgery approaches and techniques from literally every possible angle.”

“We are extremely proud of our engineering and manufacturing teams for creating such a robust collection of devices,” added Pontecorvo, “all with the highest structural integrity and quality standards, and we look forward to the remainder of 2022 and a pipeline full of additional product offerings.”

With further expansions to its lines of award-winning Spira and Enza technology platforms due later this year, along with training labs and educational programs to support ALIF, LLIF, OLIF, PLIF and TLIF spine surgery techniques, the company is focused on fulfilling its mission to support the full array of surgical approaches.

The Camber Spine collection of devices will be on display at the American Association of Neurological Surgeons (AANS) Annual Meeting at the Pennsylvania Convention Center (booth #204 on the exhibit floor.  Camber’s booth will also be hosting a series of focus sessions:

  • “Posterior Approach” April 30 at 10:00am;
  • “Advanced Biologics” April 30 at 1:00pm; and
  • “Anterior Column” May 1 at 10:00am.

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.